Pharma exporters eye ‘preferential treatment’ by US
The US’ threat to impose reciprocal tariff from April 2 on Indian exports has received mixed reaction from the domestic pharma sector. A section of the industry are hoping for…
Parameters for evaluating FDCs should be changed: IDMA
The Sub-committee of Drugs Technical and Advisory Board (DTAB) is examining the fixed-dose combinations (FDCs) which are considered irrational by Prof Kokate Committee. The committee has asked the concerned applicants to…